Search for: "Apotex, Inc. " Results 261 - 280 of 672
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
9 Jun 2014, 4:00 am by Matrix Legal Information Team
  On Tuesday 10 June 2014, the Court will hear the appeal of Les Laboratoires Servier & Anor v Apotex Inc & Ors in Court 2 from 10.00 am. [read post]
16 May 2014, 4:42 am by Lawrence B. Ebert
Apotex, Inc., 480 F.3d 1348, 1361 (Fed. [read post]
27 Apr 2014, 9:01 pm by Patent Docs
• Defendants: Apotex, Inc.; Apotex Corp. [read post]
24 Apr 2014, 9:55 pm by Patent Docs
• Defendants: Apotex Corp.; Apotex Inc. [read post]
14 Apr 2014, 9:59 pm by Patent Docs
Apotex Inc. that is a cautionary tale of patent lifecycle and the difficulties those seeking to extend patent protection face -- namely the blooming of prior art relating to an approved product. [read post]
13 Apr 2014, 10:00 pm by Courtenay Brinckerhoff
Apotex, Inc., the Federal Circuit affirmed the district court’s summary judgment that two Roche Boniva patents are invalid as obvious. [read post]
11 Apr 2014, 11:29 am
Apotex Inc., No. 2013-1128, -1161, -1162, -1163, -1164 (April 11, 2014).IssueThe issue in this case is whether it would have been obvious at the time of invention to select a once monthly oral dosing regimen of ibandronate to treat osteoporosis and to set that dose at 150 mg [based on prior art references teaching a daily dosage amount].Hoffmann-La Roche, Inc. at *9 (text added).Holding[T]he prior art pointed to a monthly treatment of 150 mg of ibandronate. [read post]
7 Apr 2014, 9:59 pm by Patent Docs
The case involved patentee Senju Pharmaceutical's (joined by Kyorin Pharmaceutical Co. and Allergan, Inc.) suit against Apotex in response to a Paragraph IV certification against Senju's patented ocular antimicrobial agent containing the drug Gatifloxacin as claimed in U.S. [read post]
3 Apr 2014, 9:55 pm by Patent Docs
• Defendants: Apotex Inc.; Apotex Corp. [read post]
29 Jan 2014, 9:12 pm by Lawrence B. Ebert
Apotex, Inc., 480 F.3d 1348, 1372 (Fed. [read post]
14 Jan 2014, 9:30 am by Shaunna Mireau
Apotex Inc., 2013 FC 1265 (CanLII) (December 18, 2013) [60] Roche has claimed $1,288.86 for Quicklaw and Westlaw fees. [read post]